AI assistant
Sending…
DEXCOM INC — Director's Dealing 2010
May 17, 2010
30198_dirs_2010-05-17_658b4144-ecc7-48e2-b927-7faffdd5b8a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-05-13
Reporting Person: MOY JEFFREY (V. P., Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-13 | Common Stock | M | 3593 | $7.63 | Acquired | 71244 | Direct |
| 2010-05-13 | Common Stock | M | 3013 | $6.33 | Acquired | 74257 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-13 | Incentive Stock Option (right to buy) | $6.33 | M | 3013 | Disposed | 2018-09-24 | Common Stock (3013) | Direct |
| 2010-05-13 | Incentive Stock Option (right to buy) | $7.63 | M | 3593 | Disposed | 2018-05-19 | Common Stock (3593) | Direct |
Footnotes
F1: The option vests and becomes exercisable with respect to 1/4th of the shares one year after the date of grant, and thereafter continues to vest and become exercisable as to 1/48th of the shares each month thereafter (with the shares fully vested on the 4th anniversary of the date of grant).
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17